However, in an examination of a wide panel of cytokines and chemokines (CCL1, CCL2, CCL3, CCL22, CXCL11, CXCL13, and IL-16) in the cerebrospinal fluid of relapsing-remitting MS patients, only CCL3 was found to be associated with both MS diagnosis and oligoclonal IgG, a typical marker for inflammation in MS [338]. The gene discussed is CCL22; the disease is myeloid sarcoma.